irinotecan,leucovorin,oxaliplatin,nab-paclitaxel,gemcitabine
Ipsen
[]
napoli3. nalirifox new first line standard of care in mpdac patients. os pfs orr 42 vs 36%
- different toxicities profile
#ascogi23 
Medical Oncologist

Gastrointestinal Cancer Department 

Hospital Clínic de Barcelona